Skip to main content

Research

New
History

Explore

Search
Cases
Professionals

Resources

Blog
Pricing
Docs

Sign in Create account

Cases

CourtFilingsPetition dateMore filters

Case

Funded debt

Stage

Exit

Next hearing

Last activity

Petition date

Court

BIND Therapeutics, Inc.

Sale Process

Case No. 16-11084·Delaware·Petition date May 1, 2016

Research this case Track this case Sign in

OverviewProfessionals

Professionals

Retained professionals and compensation participants, joined to their source filings.

C

Cowen and Company, LLC

Retained · fee applicantInvestment Banker · Debtor

Dkt. 52

D

Development Specialists, Inc.

RetainedChief Restructuring Officer · Debtor

Dkt. 340

I

IPmetrics LLC

Retained · fee applicantValuation / Appraiser · Debtor

Dkt. 175

L

Latham & Watkins LLP

Retained · fee applicantBankruptcy Counsel · Debtor

Dkt. 50

P

Prime Clerk LLC

Fee applicant

R

Richards P.C.

Fee applicant

R

Richards, Layton & Finger, P.A.

Retained · fee applicantBankruptcy Counsel · Debtor

Dkt. 49

Judge: Brendan Linehan Shannon
Petition assets: $10M–$50M
Petition liabilities: $10M–$50M
Industry: Healthcare
Debtors: 2

BIND Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, specializing in the development of targeted therapeutics for cancer treatment. The company utilizes its proprietary Medicinal Nanoengineering® platform to produce ACCURINS®, which are polymeric nanoparticles designed for enhanced drug delivery and controlled release. As of May 2016, the company maintained 65 full-time employees, a portfolio of over 20 issued U.S. patents, and collaborative research agreements with major pharmaceutical firms.

Case background, summaries, and key terms are generated from the filings on this docket. Docket entries and documents come from the court.

Report a data error